Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid vs Adrenaline for Endobronchial Bleeding
NCT07759089Completed
- Sponsor
- Sheikh Zayed Federal Postgraduate Medical Institute
- Start
- Jan 2022
- Primary completion
- Jan 2023
- Countries
- 1
01
Overview
Randomised, open-label trial of tranexamic acid (2 arms), sponsored by Sheikh Zayed Federal Postgraduate Medical Institute. Primary endpoint: Immediate Hemostasis (Bleeding Cessation). Started Jan 2022; status: completed.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on NCT07759089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07759089.